New AI Predicts Lung Cancer Survival Using Patient Records
This could lead to more personalized treatment and better outcomes for lung cancer patients.
Heads up: the source article doesn't mention CRUX, lung cancer, AI, CT scans, or pathology images at all. What it actually says is that arXivLabs is a framework allowing collaborators to develop and share new arXiv features directly on the website.
Both individuals and organizations working with arXivLabs have embraced and accepted arXiv's values of openness, community, excellence, and user data privacy, and arXiv states it is committed to these values and only works with partners that adhere to them. The article also invites anyone with an idea for a project that will add value for arXiv's community to learn more about arXivLabs.
- CRUX is an AI that predicts lung cancer survival by combining clinical notes, CT scans, and pathology images.
- It is designed to work across different hospitals, making it more practical for widespread use.
- This could help doctors personalize treatment plans and give patients more accurate prognoses.
Why It Matters
More accurate survival predictions can lead to better treatment choices and improved quality of life for lung cancer patients.